[Federal Register Volume 84, Number 32 (Friday, February 15, 2019)]
[Notices]
[Pages 4469-4470]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02495]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-19-18FJ]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Evaluation of the Chronic Disease Self-
Management Program in the US Affiliated Pacific Islands to the Office 
of Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on February 2, 2018 to obtain comments from 
the public and affected agencies. CDC did not receive comments related 
to the previous notice. This notice serves to allow an additional 30 
days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Evaluation of the Chronic Disease Self-Management Program in the US 
Affiliated Pacific Islands--New--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    NCCDPHP plans to evaluate the first ever implementation of Stanford 
University's Chronic Disease Self-Management Program (CDSMP) in the US 
Affiliated Pacific Islands (USAPIs). CDSMP is a 6-week series of 
workshops for people with arthritis, diabetes, lung disease, cancer, 
and other health problems. The workshops focus on helping participants 
learn strategies to manage chronic disease, including techniques to 
deal with problems such as frustration, fatigue, pain and isolation; 
appropriate exercise for maintaining and improving strength, 
flexibility, and endurance; and appropriate use of medications among 
others. Proven benefits of CDSMP include decreased pain and health 
distress, increased energy and fatigue, increased physical activity, 
better communication with health care providers, and increased 
confidence in managing chronic disease.
    The program will be offered repeatedly over the course of three 
years, which will cover repeated data collections in the USAPIs. These 
jurisdictions include American Samoa, Guam, the Commonwealth of the 
Northern Mariana Islands, the Republic of Palau, the Republic of the 
Marshall Islands, and the Federated States of Micronesia. Because this 
is the first time CDSMP is being implemented in the USAPIs, we do not 
know if the intervention, which has proven to improve health outcomes 
in many ethnic groups within the United States, will lead to improved 
health outcomes for these communities.
    The purpose of the evaluation is to understand how CDSMP is being 
implemented in the region, to identify barriers and facilitators to 
implementation, to monitor fidelity to Stanford University's model and 
document adaptations to the curriculum, and to understand the self-
reported effects of the program on program participants. The estimated 
annual burden hours are 95. There are no costs to respondents other 
than their time.

[[Page 4470]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Program Participant...................  Chronic Disease Self-                190               1           10/60
                                         Management Workshop
                                         Evaluation.
Program Participant...................  Chronic Disease Self-                190               2           10/60
                                         Management
                                         Questionnaire (Pre-Post
                                         Test).
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-02495 Filed 2-14-19; 8:45 am]
 BILLING CODE 4163-18-P